A significant discovery in cancer research is occurring with the use of mini-antibodies to re-engage mutated p53. This essential malignant inhibitor protein is frequently disabled in many kinds of malignancies, leading https://get-social-now.com/story7424030/vhh-fragments-revive-the-p53-protein-the-new-hope-for-malignant-management